Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2014

Nov 12, 2014

32853_dirs_2014-11-12_454d7226-3c48-4b7d-895c-216a3e620af0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2014-11-07

Reporting Person: Yow Mai Chan (See Remarks)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-11-07 Common Stock M 1300 $14.60 Acquired 2116 Direct
2014-11-07 Common Stock S 1300 $29.2596 Disposed 816 Direct
2014-11-10 Common Stock M 8700 $14.60 Acquired 9516 Direct
2014-11-10 Common Stock S 8700 $29.0038 Disposed 816 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-11-07 Employee Stock Option (Right to Buy) $14.6 M 1300 Disposed 2021-05-17 Common Stock (1300.0) Direct
2014-11-10 Employee Stock Option (Right to Buy) $14.6 M 8700 Disposed 2021-05-17 Common Stock (8700.0) Direct

Footnotes

F1: The sales reported by Ms. Yow were effected pursuant to a Rule 10b5-1 trading plan adopted on August 22, 2014.

F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F4: 1/48th of the shares subject to the Option vested on June 18, 2011 and 1/48th of the shares subject to the Option vest each month thereafter, such that the Option will be fully vested on May 18, 2015.